In the May 2020 issue of International Clinical Trials, Jessica Kim introduces study-life balance – a new construct that leverages patient-centric solutions to help patients more easily integrate clinical trial participation into their daily lives. By putting clinical trial participation within the context of the patient’s entire life experience, study-life balance marks an evolution in the patient experience.
With the disruption caused by COVID-19, this construct could not be more timely for patients seeking to continue clinical trial participation or planning ahead for future enrollment.
Note: This article is taken from International Clinical Trials May 2020, page 50-53. © Samedan Ltd.
Jessica Kim
As Director of Research and Digital Strategy for BBK Worldwide, Jessica spearheads the development of new engagement strategies to enhance the clinical trial patient and site experience.